EventsThe 3rd International Online Conference on Vaccines
Published
This submission belongs to the session S5. New Methods for Vaccine Delivery of the event The 3rd International Online Conference on Vaccines
Published date
21 Nov, 2025
Academic Editor
author-avatarSilvio Tafuri
Citation
Banjo Christianah Tolani, Taiwo Esther Odunayo, Thermostable and Needle-Free Vaccine Delivery Technologies: Prospects for Expanding Immunization Access in Nigeria, in Proceedings of The 3rd International Online Conference on Vaccines, 26 November–28 November 2025, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

Thermostable and Needle-Free Vaccine Delivery Technologies: Prospects for Expanding Immunization Access in Nigeria

Taiwo Esther Odunayo 1
1. Department of Medical Microbiology and Parasitology, College of Medicine, University of Lagos, Lagos, Nigeria, 5256, Marina, Lagos, Nigeria., Nigeria
Abstract

Despite considerable progress in immunization efforts, Nigeria continues to face significant challenges in delivering vaccines to remote and underserved areas. The dependence on cold-chain infrastructure, coupled with vaccine hesitancy and limited healthcare access, has hindered equitable vaccine distribution. Recent advances in thermostable and needle-free vaccine delivery platforms offer promising alternatives that can improve immunization coverage, especially in hard-to-reach populations. This study aims to assess the challenges and opportunities associated with the deployment of thermostable and needle-free vaccine delivery technologies in Nigeria, with an emphasis on their applicability in low-resource and rural settings. This is a secondary data review based on recent literature and reports from 2020 to 2024. Sources included peer-reviewed journals, WHO technical documents, and national immunization data. Key indicators analyzed include vaccine storage requirements, ease of administration, cost-effectiveness, and public health outcomes. Thermostable vaccines—formulations that remain effective without strict cold storage—have shown promise in reducing vaccine wastage and improving delivery logistics. Additionally, needle-free technologies such as microneedle patches, jet injectors, and nasal sprays have demonstrated comparable immunogenicity to traditional methods and could address needle-associated fears and safety concerns. Although pilot studies have shown efficacy and acceptance, widespread adoption in Nigeria is limited by cost, regulatory bottlenecks, and healthcare worker training gaps. Thermostable and needle-free vaccine platforms represent a transformative step toward equitable vaccine access in Nigeria. Policy reforms, investment in scalable technologies, and pilot programs are crucial for integration into national immunization schedules. Further studies should evaluate community acceptance and long-term cost-effectiveness in the Nigerian context.

Keywords
Thermostable vaccines
needle-free delivery
immunization
Nigeria
microneedle patches
public health
cold chain
Comparative analysis of the immunogenicity of mRNA-H5 vaccine delivered by needle-free jet injection and lipid nanoparticles
Challenges and Prospects of Vectored Vaccine Platforms in the Nigerian Public Health System